Captor Capital Corp.

CPTR

CA14075H2028

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 07:50:16 06/05/2024 pm IST			5-day change	1st Jan Change
0.05 ^CAD	-16.67%		-16.67%	-47.37%

29/02	Captor Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Captor Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Captor Capital Corp. Reports Earnings Results for the First Quarter Ended June 30, 2023

August 29, 2023

Captor Capital Corp. reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was CAD 9.24 million compared to CAD 11.07 million a year ago.

Net loss was CAD 0.463228 million compared to CAD 1.12 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.

Latest news about Captor Capital Corp.

Captor Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01/03	CI
Captor Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	30/11	CI
Captor Capital Corp. Reports Earnings Results for the First Quarter Ended June 30, 2023	29/23/29	CI
Captor Capital Corp. Reports Earnings Results for the Full Year Ended March 31, 2023	28/23/28	CI
Rimstock Holdings Limited cancelled the acquisition of Captor Capital Corp. in a reverse merger transaction.	26/23/26	CI
Captor Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	02/23/02	CI
An unknown buyer acquired a 8% stake in Captor Capital Corp. from SOL Global Investments Corp. for CAD 1.7 million.	04/23/04	CI
Captor Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	30/22/30	CI
Captor Capital Corp. Announces the Resignation of Alex Spiro from Board of Directors	30/22/30	CI
Captor Capital Corp. Reports Earnings Results for the First Quarter Ended June 30, 2022	30/22/30	CI
Captor Capital Corp. Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI
Captor Capital Signs Letter of Intent for Reverse Takeover Transaction with Rimstock Holdings	18/22/18	MT
Rimstock Holdings Limited entered into a binding letter of intent to acquire Captor Capital Corp. for $31.7 million in a reverse merger transaction.	18/22/18	CI
Captor Capital Details Strategic Review, To Be Led By Cannabis Industry Veteran	22/22/22	MT
Captor Capital Corp. Announces Appointment of Brady Cobb as Interim Chairman of the Board, Effective from July 1, 2022	22/22/22	CI
Captor Capital Corp. cancelled the acquisition of remaining 49% stake in Captor Retail Group Inc. from group of sellers.	21/22/21	CI
Captor Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	02/22/02	CI
Captor Capital Corp. entered into a definitive stock purchase agreement to acquire remaining 49% stake in Captor Retail Group Inc. from group of sellers for CAD 29.7 million.	14/21/14	CI
Captor Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	29/21/29	CI
Captor Capital Corp Announces That It Has Enters into A Binding Agreement to Purchase A Majority Interest in A Licensed Dispensary Location in Pacifica, California	17/21/17	CI
Captor Capital Corp. (CNSX : CPTR) entered into a binding agreement to acquire a majority interest in licensed dispensary location in Pacifica, California.	17/21/17	CI
Tranche Update on Captor Capital Corp.'s Equity Buyback Plan announced on May 5, 2020.	30/21/30	CI
Captor Capital Corp. Reports Earnings Results for the Full Year Ended March 31, 2021	30/21/30	CI
Captor Capital Announces Opening of ‘One Plant California’ Retail Cannabis Dispensary in Goleta, California	27/21/27	CI
Captor Capital Corp. Announces Board Changes	18/21/18	CI

Chart Captor Capital Corp.

Duration

Period

More charts

Company Profile

Captor Capital Corp. is a Canada-based investment firm focused on the cannabis sector. The Company's principal business activity is the retail sale of cannabis products. The Company has a retail license for selling of cannabis products in the state of California, United States. The Company's segments include Canada, United States, and Other. The Company provides recreational cannabis products to consumers, as well as other cannabis-based goods directly to California consumers through its retail locations and online and delivery networks. The Company has seven cannabis dispensaries, which operate under the proprietary name One Plant, located in Santa Cruz, Antioch, Salinas, Lompoc, Goleta, Atwater and Castroville (the Dispensaries). Supplementing the brick-and-mortar retail presence is the Company's direct to consumer delivery business, which also operates under the One Plant brand.

Sector

Pharmaceuticals

Calendar

07/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
CAPTOR CAPITAL CORP.	-47.37%	1.9M
DONG-E-E-JIAO CO.,LTD.	+43.33%	6.3B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.78%	4.44B
TASLY PHARMACEUTICAL GROUP CO., LTD	-6.93%	3.27B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.89%	3.16B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.88%	2.58B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+46.64%	1.96B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-5.34%	1.73B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+1.60%	1.68B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-7.31%	1.63B

Alternative Medicine